FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Massimo Loda

Research Profile

Disorders

Physiology

Procedures

Living Beings

Mouse

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Genes, Tumor Suppressor

Co-author Network

Publications

TOP 3
Kathryn L Penney; Howard D Sesso; Meir J Stampfer; Haojie Li; Massimo Loda; Lorelei A Mucci; Jing Ma
Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Esther Baena; Roderick T Bronson; Yuko Fujiwara; Kimberly Glass; Frank J Godinho; Melanie J Hamblen; Jonghwan Kim; Douglas E Linn; Massimo Loda; Lorelei A Mucci; Minh Nguyen; Stuart H Orkin; Zhen Shao; Guo-Cheng Yuan; Xin Zhang; Zhe Li
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
Changmeng Cai; Sen Chen; Christopher Fiore; Housheng Hansen He; Lingfeng He; X Shirley Liu; Massimo Loda; Fen Ma; Lorelei Mucci; Adam Sowalsky; Hongyun Wang; Qianben Wang; Steven P Balk; Myles Brown; Xin Yuan
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Massimo Loda (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kathryn L Penney; Howard D Sesso; Meir J Stampfer; Haojie Li; Massimo Loda; Lorelei A Mucci; Jing Ma
Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
The Prostate 2013;73(7):700-5.
2013: Esther Baena; Roderick T Bronson; Yuko Fujiwara; Kimberly Glass; Frank J Godinho; Melanie J Hamblen; Jonghwan Kim; Douglas E Linn; Massimo Loda; Lorelei A Mucci; Minh Nguyen; Stuart H Orkin; Zhen Shao; Guo-Cheng Yuan; Xin Zhang; Zhe Li
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
Genes & development 2013;27(6):683-98.
2013: Changmeng Cai; Sen Chen; Christopher Fiore; Housheng Hansen He; Lingfeng He; X Shirley Liu; Massimo Loda; Fen Ma; Lorelei Mucci; Adam Sowalsky; Hongyun Wang; Qianben Wang; Steven P Balk; Myles Brown; Xin Yuan
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.
The Journal of clinical investigation 2013;123(3):1109-22.
2013: Peiman Habibollahi; Darshini Kuruppu; Massimo Loda; Nynke S van den Berg; Umar Mahmood
Metformin--an adjunct antineoplastic therapy--divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(2):252-8.
2013: Jennifer C Melvin; Sabine Rohrmann; Lars Holmberg; Massimo Loda; Mieke Van Hemelrijck
Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.
Journal of cancer epidemiology 2013;2013():823849.
2013: Shidong Jia; Sang Hyun Lee; Massimo Loda; Sauveur-Michel Maira; Sabina Signoretti; Edward C Stack; Xiaoqiu Wu; Jean J Zhao; Xueliang Gao; Thomas M Roberts
Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention.
Cancer discovery 2013;3(1):44-51.
2012: Kexin Xu; Steven P Balk; Changmeng Cai; Laura Cato; Richard I Gregory; Anna C Groner; Housheng Hansen He; Philip W Kantoff; Rosina T Lis; Tao Liu; X Shirley Liu; Massimo Loda; Cristina Magi-Galluzzi; Rodolfo Montironi; Colm Morrissey; Edward C Stack; James E Thornton; Robert L Vessella; Xiaoqiu Wu; Zhenhua Jeremy Wu; Han Xu; Myles Brown
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.
Science (New York, N.Y.) 2012;338(6113):1465-9.
2012: Richard Flavin; Eoin Gaffney; Helen Ingoldsby; Massimo Loda; John J O'Leary; Esther O'Regan; Martina Ring; Miranda Rogers; Ciara Barrett; Toni K Choueiri; Stephen P Finn; Sabina Signoretti; Paul Smyth; Orla Sheils
RET protein expression in papillary renal cell carcinoma.
Urologic oncology 2012;30(6):900-5.
2012: Andreas Pettersson; Michael J Pitt; Jennifer R Rider; Martin G Sanda; Howard D Sesso; Edward C Stack; Meir J Stampfer; Catherine Suppan; Christopher Sweeney; Scott R Bauer; Eric L Ding; Michelangelo Fiorentino; Richard Flavin; Edward L Giovannucci; Rebecca E Graff; Philip W Kantoff; Lauren Kunz; Azra H Ligon; Rosina T Lis; Massimo Loda; Neil E Martin; Kathryn L Penney; Lorelei A Mucci
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1497-509.
2012: Chiara Grisanzio; William C Hahn; Philip W Kantoff; Masahito Kido; Robert Leung; Rosina Lis; Massimo Loda; Ian Mills; David E Neal; Gillian Petrozziello; Mark M Pomerantz; Brian D Robinson; Helen Ross-Adams; Oliver Sartor; Anna C Schinzel; Prasanna Sooriakumaran; Edward C Stack; David Takeda; Ashutosh K Tewari; Lillian Werner; Hiroki Yamada; Toshihiro Yamamoto; Bisola C Awoyemi; Shin Egawa; Matthew L Freedman
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(28):11252-7.
2012: Christopher Fiore; Michelangelo Fiorentino; Massimo Loda; Neil Martin; Xiaoqiu Wu; Swen-Olof Andersson; Ove Andren; Dyane Bailey; Niamh Conlon; Katja Fall; Stephen Finn; Richard Flavin
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry.
Journal of clinical pathology 2012;65(6):496-502.
2012: Xinqi Wu; Jun Zhou; Elisa Benedettini; Pasi A Janne; Massimo Loda; Andrew M Rogers; F Stephen Hodi
c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
Melanoma research 2012;22(2):123-32.
2012: Jayoung Kim; Wun-Jae Kim; Zhiqian Liu; Massimo Loda; Michael R Freeman
The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.
Cell cycle (Georgetown, Tex.) 2012;11(6):1123-30.
2012: Barbara Benassi; Giovanni Blandino; Dipanjan Chowdhury; Richard Flavin; Marina Marani; LUIGI MARCHIONNI; Paola Muti; Yunfeng Pan; Sabrina Strano; Silvio Zanata; Massimo Loda
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.
Cancer discovery 2012;2(3):236-47.
2012: Jayoung Kim; Massimo Loda; Sungyong You; Susan K Keay; Michael R Freeman
A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2.
PloS one 2012;7(12):e50392.
2012: Justin M Craig; Charles G Eberhart; Shaun D Fouse; D Ashley Hill; Ahmed Idbaih; Mark W Kieran; Keith L Ligon; Massimo Loda; Linda R Margraf; Andrew D Norden; Memet Ozek; Shakti Ramkissoon; Sandro Santagata; AYDIN SAV; Natalie Vena; Patrick Y Wen; Azra H Ligon
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.
PloS one 2012;7(6):e38881.
2011: Kathryn L Penney; Sven Perner; Mark A Rubin; Howard D Sesso; Sunita Setlur; Jennifer A Sinnott; Meir J Stampfer; Jennifer R Stark; Yudi Pawitan; Hans-Olov Adami; Swen-Olof Andersson; Ove Andrén; Stefano Calza; Katja Fall; Stephen Finn; Michelangelo Fiorentino; Richard Flavin; Matthew L Freedman; Todd R Golub; Yujin Hoshida; Jan-Erik Johansson; Philip W Kantoff; Peter Kraft; Massimo Loda; Neil Martin; Lorelei A Mucci
mRNA expression signature of Gleason grade predicts lethal prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2391-6.
2011: Whitney K Hendrickson; Philip W Kantoff; Julie L Kasperzyk; Rosina Lis; Massimo Loda; Jing Ma; Lorelei A Mucci; Kathryn L Penney; Meir J Stampfer; Fang Fang; Christopher Fiore; Michelangelo Fiorentino; Richard Flavin; Edward Giovannucci
Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2378-85.
2011: Anna R Laury; Ruth Perets; Huiying Piao; Jeffrey F Krane; Justine A Barletta; Christopher French; Lucian R Chirieac; Rosina Lis; Massimo Loda; Jason L Hornick; Ronny Drapkin; Michelle S Hirsch
A comprehensive analysis of PAX8 expression in human epithelial tumors.
The American journal of surgical pathology 2011;35(6):816-26.
2011: Sang Hyun Lee; Shidong Jia; Yanni Zhu; Tamara Utermark; Sabina Signoretti; Massimo Loda; Brian Schaffhausen; Thomas M Roberts
Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.
Journal of virology 2011;85(11):5581-92.
2011: Caterina Nardella; George Thomas; Andrea Alimonti; John G Clohessy; Giuseppe Fedele; Sara C Kozma; Massimo Loda; Andrea Lunardi; Pier Paolo Pandolfi
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis.
Cancer research 2011;71(10):3669-75.
2011: Paul L Nguyen; Douglas I Lin; Junyi Lei; Michelangelo Fiorentino; Elke Mueller; Michael H Weinstein; Michele Pagano; Massimo Loda
The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy.
Urologic oncology 2011;29(3):302-8.
2011: Craig J Ceol; Yariv Houvras; Judit Jane-Valbuena; Steve Bilodeau; David A Orlando; Valentine Battisti; Lauriane Fritsch; William M Lin; Travis J Hollmann; Fabrizio Ferré; Caitlin Bourque; Christopher J Burke; Laura Turner; Audrey Uong; Laura A Johnson; Rameen Beroukhim; Craig H Mermel; Massimo Loda; SLIMANE AIT-SI-ALI; Levi A Garraway; Richard A Young; Leonard I Zon
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.
Nature 2011;471(7339):513-7.
2011: Mariam Anees; Peter Horak; Ahmed El-Gazzar; Martin Susani; Georg Heinze; Paul Perco; Massimo Loda; Rosina Lis; michael krainer; William K Oh
Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.
Cancer 2011;117(6):1172-82.
2011: Zhihu Ding; Chang-Jiun Wu; Gerald Chu; Yonghong Xiao; Dennis Ho; Jingfang Zhang; Samuel R Perry; Emma S Labrot; Xiaoqiu Wu; Rosina Lis; Yujin Hoshida; David Hiller; Baoli Hu; Shan Jiang; Hongwu Zheng; Alexander H Stegh; Kenneth L Scott; Sabina Signoretti; Nabeel Bardeesy; Y Alan Wang; David E Hill; Todd R Golub; Meir J Stampfer; Wing H Wong; Massimo Loda; Lorelei Mucci; Lynda Chin; Ronald A DePinho
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
Nature 2011;470(7333):269-73.
2011: Patrick A Kenney; Matthew F Wszolek; Kimberly M Rieger-Christ; Brasil Silva Neto; Justin J Gould; Niall J Harty; Juan Miguel Mosquera; Ron Zeheb; Massimo Loda; Douglas Darling; John A Libertino; Ian C Summerhayes
Novel ZEB1 expression in bladder tumorigenesis.
BJU international 2011;107(4):656-63.
2011: Richard Flavin; Giorgia Zadra; Massimo Loda
Metabolic alterations and targeted therapies in prostate cancer.
The Journal of pathology 2011;223(2):283-94.
2010: Mark M Pomerantz; Yashaswi Shrestha; Richard Flavin; Meredith M Regan; Kathryn L Penney; Lorelei A Mucci; Meir J Stampfer; David J Hunter; STEPHEN CHANOCK; Eric J Schafer; Jennifer A Chan; Josep Tabernero; José Baselga; Andrea L Richardson; Massimo Loda; William K Oh; Philip W Kantoff; William C Hahn; Matthew L Freedman
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.
PLoS genetics 2010;6(11):e1001204.
2010: Y Baba; Katsuhiko Nosho; K Shima; Jeffrey A Meyerhardt; A T Chan; Jeffrey A Engelman; Lewis C Cantley; Massimo Loda; E Giovannucci; Charlie S Fuchs; Shuji Ogino
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.
British journal of cancer 2010;103(7):1025-33.
2010: Paul Nguyen; Jing Ma; Jorge E Chavarro; Matthew L Freedman; Rosina Lis; Giuseppe Fedele; Christopher Fiore; Weiliang Qiu; Michelangelo Fiorentino; Stephen Finn; Kathryn L Penney; Anna Eisenstein; Fredrick R Schumacher; Lorelei A Mucci; Meir J Stampfer; Edward Giovannucci; Massimo Loda
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):3958-64.
2010: Mara S Meyer; Kathryn L Penney; Jennifer R Stark; Fredrick R Schumacher; Howard D Sesso; Massimo Loda; Michelangelo Fiorentino; Stephen Finn; Richard J Flavin; Tobias Kurth; Alkes L Price; Edward L Giovannucci; Katja Fall; Meir J Stampfer; Jing Ma; Lorelei A Mucci
Genetic variation in RNASEL associated with prostate cancer risk and progression.
Carcinogenesis 2010;31(9):1597-603.
2010: Birgitta Grundmark; Hans Garmo; Massimo Loda; Christer Busch; Lars Holmberg; Björn Zethelius
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(8):2088-96.
2010: Elisa Benedettini; Lynette M Sholl; Michael Peyton; John Reilly; Christopher Ware; Lenora Davis; Natalie Vena; Dyane Bailey; Beow Y Yeap; Michelangelo Fiorentino; Azra H Ligon; Bo-Sheng Pan; Victoria M Richon; John D Minna; Adi F Gazdar; Giulio Draetta; Silvano Bosari; Lucian R Chirieac; Bart Lutterbach; Massimo Loda
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis.
The American journal of pathology 2010;177(1):415-23.
2010: Giorgia Zadra; Carmen Priolo; Akash Patnaik; Massimo Loda
New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(13):3322-8.
2010: Sang Hyun Lee; George Poulogiannis; Saumyadipta Pyne; Shidong Jia; Lihua Zou; Sabina Signoretti; Massimo Loda; Lewis Clayton Cantley; Thomas M Roberts
A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(24):11002-7.
2010: L M Flores; D W Kindelberger; Azra H Ligon; Marzia Capelletti; M Fiorentino; Massimo Loda; E S Cibas; Pasi A Janne; Ian Krop
Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.
British journal of cancer 2010;102(10):1495-502.
2010: Valentina Vaira; Giuseppe Fedele; Saumyadipta Pyne; Ester Fasoli; Giorgia Zadra; Dyane Bailey; Eric Snyder; Alice Faversani; Guido Coggi; Richard Flavin; Silvano Bosari; Massimo Loda
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(18):8352-6.
2010: Michelangelo Fiorentino; Gregory Judson; Kathryn Penney; Richard Flavin; Jennifer Stark; Christopher Fiore; Katja Fall; Neil Martin; Jing Ma; Jennifer Sinnott; Edward Giovannucci; Meir Stampfer; Howard D Sesso; Philip W Kantoff; Stephen Finn; Massimo Loda; Lorelei Mucci
Immunohistochemical expression of BRCA1 and lethal prostate cancer.
Cancer research 2010;70(8):3136-9.
2010: Massimo Loda; William G Kaelin
Prostate cancer: beta control your hormones.
Cancer cell 2010;17(4):311-2.
2010: Richard Flavin; Stephane Peluso; Paul L Nguyen; Massimo Loda
Fatty acid synthase as a potential therapeutic target in cancer.
Future oncology (London, England) 2010;6(4):551-62.
2010: Carmen Priolo; Michelle Agostini; Natalie Vena; Azra H Ligon; Michelangelo Fiorentino; Eyoung Shin; Antonella Farsetti; Alfredo Pontecorvi; Ewa Sicinska; Massimo Loda
Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.
The American journal of pathology 2010;176(4):1901-13.
2010: Junxia Min; Alexander Zaslavsky; Giuseppe Fedele; Sara K McLaughlin; Elizabeth E Reczek; Thomas De Raedt; Isil Guney; David E Strochlic; Laura E Macconaill; Rameen Beroukhim; Roderick T Bronson; Sandra Ryeom; William C Hahn; Massimo Loda; Karen Cichowski
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB.
Nature medicine 2010;16(3):286-94.
2010: Anita Wolfer; Ben S Wittner; daniel irimia; Richard J Flavin; Mathieu Lupien; Ruwanthi N Gunawardane; Clifford A Meyer; Eric S Lightcap; Pablo Tamayo; Jill P Mesirov; X Shirley Liu; Toshi Shioda; Mehmet Toner; Massimo Loda; Myles Brown; Joan S Brugge; Sridhar Ramaswamy
MYC regulation of a "poor-prognosis" metastatic cancer cell state.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(8):3698-703.
2010: Michelangelo Fiorentino; Elisa Capizzi; Massimo Loda
Blood and tissue biomarkers in prostate cancer: state of the art.
The Urologic clinics of North America 2010;37(1):131-41, Table of Contents.
2010: Laura Poliseno; Leonardo Salmena; Luisa Riccardi; Alessandro Fornari; Min Sup Song; Robin M Hobbs; Paolo Sportoletti; Shorheh Varmeh; Ainara Egia; Giuseppe Fedele; Lucia Rameh; Massimo Loda; Pier Paolo Pandolfi
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.
Science signaling 2010;3(117):ra29.
2009: Lynette M Sholl; Beow Y Yeap; A John Iafrate; Alison J Holmes-Tisch; Yi-Ping Chou; Ming-Tsang Wu; Yih-Gang Goan; Li Su; Elisa Benedettini; Jian Yu; Massimo Loda; Pasi A Janne; David C Christiani; Lucian R Chirieac
Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.
Cancer research 2009;69(21):8341-8.
2009: Bala S Balakumaran; Alessandro Porrello; David S Hsu; Wayne Glover; Adam Foye; Janet Y Leung; Beth A Sullivan; William C Hahn; Massimo Loda; Phillip G Febbo
MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy.
Cancer research 2009;69(19):7803-10.
2009: Jeffrey A Meyerhardt; Shuji Ogino; Gregory J Kirkner; Andrew T Chan; Brian M Wolpin; Kimmie Ng; Katsuhiko Nosho; Kaori Shima; Edward L Giovannucci; Massimo Loda; Charlie S Fuchs
Interaction of molecular markers and physical activity on mortality in patients with colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5931-6.
2009: Peter Reichardt; Pancras C W Hogendoorn; Elena Tamborini; Massimo Loda; Alessandro Gronchi; Andrés Poveda; Patrick Schöffski
Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues.
Seminars in oncology 2009;36(4):290-301.
2009: Eric L Snyder; Dyane Bailey; Michail Shipitsin; Kornelia Polyak; Massimo Loda
Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies.
Laboratory investigation; a journal of technical methods and pathology 2009;89(8):857-66.
2009: Justine A Barletta; Sven Perner; A John Iafrate; Beow Y Yeap; Barbara A Weir; Laura A Johnson; Bruce E Johnson; Matthew Meyerson; Mark A Rubin; William D Travis; Massimo Loda; Lucian R Chirieac
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
Journal of cellular and molecular medicine 2009;13(8B):1977-86.
2009: Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan YU; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
Cell 2009;138(2):245-56.
2009: Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3459-64.
2009: Eric L Snyder; Deborah J Sandstrom; Kenneth Law; Christopher Fiore; Ewa Sicinska; Joseph Brito; Dyane Bailey; Jonathan A Fletcher; Massimo Loda; Scott J Rodig; Paola Dal Cin; Christopher D M Fletcher
c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
The Journal of pathology 2009;218(3):292-300.
2009: Carmelo Nucera; Jerome Eeckhoute; Stephen Finn; Jason S Carroll; Azra H Ligon; Carmen Priolo; Guido Fadda; Mary Toner; Orla Sheils; Marco Attard; Alfredo Pontecorvi; Vania Nose; Massimo Loda; Myles Brown
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3680-9.
2009: Richard Flavin; Paul Smyth; Ciara Barrett; S Russell; Hannah Wen; Jianjun Wei; Alex Laios; Sharon A O'Toole; Martina Ring; Karen Denning; Jinghuan Li; S Aherne; D Sammarae; N A Aziz; A Alhadi; Stephen Finn; Massimo Loda; Sheppard B; Orla Sheils; John J O'Leary
miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(4):641-7.
2009: Jian Yu; Susan Kane; Jiong Wu; Elisa Benedettini; Daiqiang Li; Cynthia Reeves; Gregory Innocenti; Randy Wetzel; Katherine Crosby; Alison Becker; Michelle Ferrante; Wan Cheung Cheung; Xiqiang Hong; Lucian R Chirieac; Lynette M Sholl; Herbert Haack; Bradley L Smith; Roberto D Polakiewicz; Yi Tan; Ting-Lei Gu; Massimo Loda; Xinmin Zhou; Michael J Comb
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3023-8.
2009: Simona Nanni; Valentina Benvenuti; Annalisa Grasselli; Carmen Priolo; Aurora Aiello; Stefania Mattiussi; Claudia Colussi; Vittoria Lirangi; Barbara Illi; Manuela D'Eletto; Anna Maria Cianciulli; Michele Gallucci; Piero De Carli; Steno Sentinelli; Marcella Mottolese; Paolo Carlini; Lidia Strigari; Stephen Finn; Elke Mueller; Giorgio Arcangeli; carlo gaetano; Maurizio C Capogrossi; Raffaele Perrone Donnorso; Silvia Bacchetti; Ada Sacchi; Alfredo Pontecorvi; Massimo Loda; Antonella Farsetti
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.
The Journal of clinical investigation 2009;119(5):1093-108.
2009: Toshiro Migita; Stacey Ruiz; Alessandro Fornari; Michelangelo Fiorentino; Carmen Priolo; Giorgia Zadra; Fumika Inazuka; Chiara Grisanzio; Emanuele Palescandolo; Eyoung Shin; Christopher Fiore; Wanling Xie; Andrew L Kung; Phillip G Febbo; Aravind Subramanian; Lorelei Mucci; Jing Ma; Sabina Signoretti; Meir Stampfer; William C Hahn; Stephen Finn; Massimo Loda
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
Journal of the National Cancer Institute 2009;101(7):519-32.
2009: Monica M Bertagnolli; Robert S Warren; Donna Niedzwiecki; Elke Mueller; Carolyn Corlies Compton; Mark Redston; Margaret Hall; Hejin P Hahn; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Massimo Loda
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2116-22.
2009: Carmen Priolo; William K Oh; Massimo Loda
Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trials.
IDrugs : the investigational drugs journal 2009;12(3):165-8.
2009: Raymond C Wadlow; Ben S Wittner; S Aidan Finley; Henry Bergquist; Rabi Upadhyay; Stephen Finn; Massimo Loda; Umar Mahmood; Sridhar Ramaswamy
Systems-level modeling of cancer-fibroblast interaction.
PloS one 2009;4(9):e6888.
2009: Zhenbang Chen; Arkaitz Carracedo; Hui-Kuan Lin; Jason A Koutcher; Nille Behrendt; Ainara Egia; Andrea Alimonti; Brett S Carver; William Gerald; Julie T Feldstein; Massimo Loda; Pier Paolo Pandolfi
Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Science signaling 2009;2(84):ra44.
2009: Venkata Sabbisetti; Arianna Di Napoli; Apryle Seeley; Angela M Amato; Esther O'Regan; Musie Ghebremichael; Massimo Loda; Sabina Signoretti
p63 promotes cell survival through fatty acid synthase.
PloS one 2009;4(6):e5877.
2009: Caterina Nardella; Arkaitz Carracedo; Andrea Alimonti; Robin M Hobbs; John G Clohessy; Zhenbang Chen; Ainara Egia; Alessandro Fornari; Michelangelo Fiorentino; Massimo Loda; Sara C Kozma; George Thomas; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Differential requirement of mTOR in postmitotic tissues and tumorigenesis.
Science signaling 2009;2(55):ra2.
2009: Jinyan Du; Paula Bernasconi; Karl R Clauser; D R Mani; Stephen P Finn; Rameen Beroukhim; Melissa Burns; Bina Julian; Xiao P Peng; Haley Hieronymus; Rebecca L Maglathlin; Timothy A Lewis; Linda M Liau; Phioanh Nghiemphu; Ingo K Mellinghoff; David N Louis; Massimo Loda; Steven A Carr; Andrew L Kung; Todd R Golub
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.
Nature biotechnology 2009;27(1):77-83.
2008: Shuji Ogino; Katsuhiko Nosho; Jeffrey A Meyerhardt; Gregory J Kirkner; Andrew T Chan; Takako Kawasaki; Edward L Giovannucci; Massimo Loda; Charles S Fuchs
Cohort study of fatty acid synthase expression and patient survival in colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5713-20.
2008: Jessica A Mandeville; Brasil Silva Neto; Alex J Vanni; Gjanje L Smith; Kimberly M Rieger-Christ; Ron Zeheb; Massimo Loda; John A Libertino; Ian C Summerhayes
P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells.
BJU international 2008;102(11):1707-14.
2008: Michelangelo Fiorentino; Giorgia Zadra; Emanuele Palescandolo; Giuseppe Fedele; Dyane Bailey; Christopher Fiore; Paul Nguyen; Toshiro Migita; Raffaella Zamponi; Dolores Di Vizio; Carmen Priolo; Chandan Sharma; Wanling Xie; Martin E Hemler; Lorelei Mucci; Edward Giovannucci; Stephen Finn; Massimo Loda
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer.
Laboratory investigation; a journal of technical methods and pathology 2008;88(12):1340-8.
2008: Marco A Carvalho; Karina G Zecchin; Fabiana Seguin; Débora C Bastos; Michelle Agostini; A L C A Rangel; Sílvio S Veiga; Helena F Raposo; Helena C F Oliveira; Massimo Loda; Ricardo D Coletta; Edgard Graner
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
International journal of cancer. Journal international du cancer 2008;123(11):2557-65.
2008: Ali G Saad; Beow Y Yeap; Frederik B J M Thunnissen; Geraldine S Pinkus; Jack L Pinkus; Massimo Loda; David J Sugarbaker; Bruce E Johnson; Lucian R Chirieac
Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
Cancer 2008;113(8):2129-38.
2008: Ron Firestein; Adam J Bass; So Young Kim; Ian F Dunn; Serena J Silver; Isil Guney; Ellen Freed; Azra H Ligon; Natalie Vena; Shuji Ogino; Milan G Chheda; Pablo Tamayo; Stephen Finn; Yashaswi Shrestha; Jesse S Boehm; Supriya Jain; Emeric Bojarski; Craig Mermel; Jordi Barretina; Jennifer A Chan; Jose Baselga; Josep Tabernero; David E Root; Charles S Fuchs; Massimo Loda; Ramesh A Shivdasani; Matthew Meyerson; William C Hahn
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.
Nature 2008;455(7212):547-51.
2008: Richard M Levenson; Alessandro Fornari; Massimo Loda
Multispectral imaging and pathology: seeing and doing more.
Expert opinion on medical diagnostics 2008;2(9):1067-81.
2008: Tan Ince; Jerrold M Ward; Victor E Valli; Dennis Sgroi; Alexander Nikitin; Massimo Loda; Stephen M Griffey; Christopher P Crum; James M Crawford; Roderick T Bronson; Robert Cardiff
Do-it-yourself (DIY) pathology.
Nature biotechnology 2008;26(9):978-9; discussion 979.
2008: Pradip K Majumder; Chiara Grisanzio; Fionnuala O'Connell; Marc Barry; Joseph M Brito; Qing Xu; Isil Guney; Raanan Berger; Paula Herman; Rachel Bikoff; Giuseppe Fedele; Won-Ki Baek; Shunyou Wang; Katharine Ellwood-Yen; Hong Wu; Charles L Sawyers; Sabina Signoretti; William C Hahn; Massimo Loda; William R Sellers
A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.
Cancer cell 2008;14(2):146-55.
2008: Shidong Jia; Zhenning Liu; Sen Zhang; Pixu Liu; Lei Zhang; Sang Hyun Lee; Jing Zhang; Sabina Signoretti; Massimo Loda; Thomas M Roberts; Jean J Zhao
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
Nature 2008;454(7205):776-9.
2008: Dolores Di Vizio; Rosalyn M Adam; Jayoung Kim; Robert Kim; Federica Sotgia; Terence Williams; Francesca Demichelis; Keith R Solomon; Massimo Loda; Mark A Rubin; Michael P Lisanti; Michael R Freeman
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase.
Cell cycle (Georgetown, Tex.) 2008;7(14):2257-67.
2008: Juan-Miguel Mosquera; Sven Perner; Elizabeth M Genega; Martin G Sanda; Matthias D Hofer; Kirsten D Mertz; Pamela L Paris; Jeff Simko; Tarek A Bismar; Gustavo Ayala; Rajal B Shah; Massimo Loda; Mark A Rubin
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3380-5.
2008: Richard J Flavin; Paul C Smyth; Stephen P Finn; Alexandros Laios; Sharon A O'Toole; Ciara Barrett; Martina Ring; Karen M Denning; Jinghuan Li; Sinead T Aherne; Natasha A Aziz; Araibi Alhadi; Brian L Sheppard; Massimo Loda; Cara Martin; Orla M Sheils; John J O'Leary
Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(6):676-84.
2008: Rebecca S Swain; Tarik Tihan; Andrew E Horvai; Dolores Di Vizio; Massimo Loda; Peter C Burger; Bernd W Scheithauer; Grace E Kim
Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor.
Human pathology 2008;39(3):410-9.
2008: Brasil Silva Neto; Gjanje L Smith; Jessica A Mandeville; Alex J Vanni; Chad Wotkowicz; Kimberly M Rieger-Christ; Egbert Baumgart; Micah A Jacobs; Michael S Cohen; Ron Zeheb; Massimo Loda; John A Libertino; Ian C Summerhayes
Prognostic significance of altered p120 ctn expression in bladder cancer.
BJU international 2008;101(6):746-52.
2008: Takako Kawasaki; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Zhiqian Liu; Hiroyuki Yamamoto; Massimo Loda; Charlie S Fuchs; Shuji Ogino
WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(2):150-8.
2008: Alexandros Laios; Sharon A O'Toole; Richard Flavin; C Martin; Lynn Kelly; Martina Ring; Stephen Finn; Ciara Barrett; Massimo Loda; Noreen Gleeson; Tom D'Arcy; Eamon P J McGuinness; Orla Sheils; Brian L Sheppard; John O' Leary
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Molecular cancer 2008;7():35.
2007: Adam Hittelman; Shivaranjani Sridharan; Ritu Roy; Jane Fridlyand; Massimo Loda; Colin Collins; Pamela L Paris
Evaluation of whole genome amplification protocols for array and oligonucleotide CGH.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2007;16(4):198-206.
2007: Qing Xu; Pradip K Majumder; Kenneth Ross; Yeonju Shim; Todd R Golub; Massimo Loda; William R Sellers
Identification of prostate cancer modifier pathways using parental strain expression mapping.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(45):17771-6.
2007: Fengfei Wang; Lilin Wang; Christine Briggs; Ewa Sicinska; Sandra M Gaston; Harvey J Mamon; Matthew H Kulke; Raffaella Zamponi; Massimo Loda; Elizabeth Maher; Shuji Ogino; Charlie S Fuchs; Jin Li; Carlos Hader; Michael G Makrigiorgos
DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.
The Journal of molecular diagnostics : JMD 2007;9(4):441-51.
2007: Dolores Di Vizio; Federica Sotgia; Terence M Williams; Ghada S Hassan; Franco Capozza; Philippe G Frank; Richard G Pestell; Massimo Loda; Michael R Freeman; Michael P Lisanti
Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression.
Cancer biology & therapy 2007;6(8):1263-8.
2007: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Peter Kraft; Massimo Loda; Charlie S Fuchs
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
The Journal of molecular diagnostics : JMD 2007;9(3):305-14.
2007: Igor Vivanco; NICOLAOS PALASKAS; Chris Tran; Stephen P Finn; Gad Getz; Norman J Kennedy; Jing Jiao; Joshua Rose; Wanling Xie; Massimo Loda; Todd R Golub; Ingo K Mellinghoff; Roger J Davis; Hong Wu; Charles L Sawyers
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN.
Cancer cell 2007;11(6):555-69.
2007: Shuji Ogino; Takako Kawasaki; Akiyo Ogawa; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
Human pathology 2007;38(6):842-9.
2007: Sabina Signoretti; Massimo Loda
Prostate stem cells: from development to cancer.
Seminars in cancer biology 2007;17(3):219-24.
2007: Shuji Ogino; Jeffrey A Meyerhardt; Takako Kawasaki; jeffrey clark; David P Ryan; Matthew H Kulke; Peter C Enzinger; Brian M Wolpin; Massimo Loda; Charlie S Fuchs
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.
Virchows Archiv : an international journal of pathology 2007;450(5):529-37.
2007: Shuji Ogino; Takako Kawasaki; Akiyo Ogawa; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
Human pathology 2007;38(4):614-20.
2007: Shuji Ogino; Takako Kawasaki; Akiyo Ogawa; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
Human pathology 2007;38(4):585-92.
2007: Egbert Baumgart; Michael S Cohen; Brasil Silva Neto; Micah A Jacobs; Chad Wotkowicz; Kimberly M Rieger-Christ; Andreia Biolo; Ron Zeheb; Massimo Loda; John A Libertino; Ian C Summerhayes
Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1685-94.
2007: Roman K Thomas; Alissa C Baker; Ralph M Debiasi; Wendy Winckler; Thomas Laframboise; William M Lin; Meng Wang; Whei Feng; Thomas Zander; Laura MacConaill; Laura E Macconnaill; Jeffrey C Lee; Rick Nicoletti; Charlie Hatton; Mary Goyette; Luc Girard; Kuntal Majmudar; Liuda Ziaugra; Kwok-Kin Wong; Stacey Gabriel; Rameen Beroukhim; Michael Peyton; Jordi Barretina; Amit Dutt; Caroline Emery; Heidi Greulich; Kinjal Shah; Hidefumi Sasaki; Adi Gazdar; John Minna; Scott A Armstrong; Ingo K Mellinghoff; F Stephen Hodi; Glenn Dranoff; Paul Mischel; Tim F Cloughesy; Stan F Nelson; Linda M Liau; Kirsten Mertz; Mark A Rubin; Holger Moch; Massimo Loda; William Catalona; Jonathan Fletcher; Sabina Signoretti; Frederic Kaye; Kenneth C Anderson; George D Demetri; Reinhard Dummer; Stephan Wagner; Meenhard Herlyn; William R Sellers; Matthew Meyerson; Levi A Garraway
High-throughput oncogene mutation profiling in human cancer.
Nature genetics 2007;39(3):347-51.
2007: Richard Byers; Dolores Di Vizio; Fionnuala O'connell; Eleni Tholouli; Richard Levenson; Kirk Gossage; Kirk Gossard; David Twomey; Yu Yang; Elisa Benedettini; Joshua Rose; Keith L Ligon; Stephen P Finn; Todd R Golub; Massimo Loda
Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution.
The Journal of molecular diagnostics : JMD 2007;9(1):20-9.
2007: Phillip G Febbo; Mike G Mulligan; David A Slonina; Kimberly Stegmaier; Dolores Di Vizio; Paul R Martinez; Massimo Loda; Stephen C Taylor
Literature Lab: a method of automated literature interrogation to infer biology from microarray analysis.
BMC genomics 2007;8():461.
2007: Maria Nieto; Stephen Finn; Massimo Loda; William C Hahn
Prostate cancer: Re-focusing on androgen receptor signaling.
The international journal of biochemistry & cell biology 2007;39(9):1562-8.
2007: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Taiki Yamaji; Massimo Loda; Charlie S Fuchs
Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(1):15-22.
2006: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.
The Journal of molecular diagnostics : JMD 2006;8(5):582-8.
2006: Angelo M DeMarzo; Elizabeth A Platz; Jonathan I Epstein; Tehmina Z Ali; Anthanase Billis; Theresa Y Chan; Liang Cheng; Milton Datta; Lars Egevad; Dilek Ertoy-Baydar; Xavier Farre; Xavier Farree; Samson W Fine; Kenneth A Iczkowski; Michael Ittmann; Beatrice S Knudsen; Massimo Loda; Antonio Lopez-Beltran; Cristina Magi-Galluzzi; Gregor Mikuz; Roldolfo Montironi; Eli Pikarsky; Galina Pizov; Mark A Rubin; Hema Samaratunga; Thomas Sebo; Isabel A Sesterhenn; Rajal B Shah; Rajiv B Shah; Sabina Signoretti; Jeffery Simko; George H Thomas; Patricia Troncoso; Toyonori T Tsuzuki; Geert J van Leenders; Ximing J Yang; Ming Zhou; William D Figg; Ashraful Hoque; Ashrafal Hoque; M S Lucia
A working group classification of focal prostate atrophy lesions.
The American journal of surgical pathology 2006;30(10):1281-91.
2006: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Akiyo Ogawa; I Dorfman; Massimo Loda; Charlie S Fuchs
Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
The Journal of pathology 2006;210(2):147-54.
2006: Eleni Tholouli; Judith A Hoyland; Dolores Di Vizio; Fionnuala O'Connell; Sarah A Macdermott; David Twomey; Richard Levenson; John A Liu Yin; Todd R Golub; Massimo Loda; Richard Byers
Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies.
Biochemical and biophysical research communications 2006;348(2):628-36.
2006: Carmen Priolo; Dan Tang; Mohan Brahamandan; Barbara Benassi; Ewa Sicinska; Shuji Ogino; Antonella Farsetti; Alessandro Porrello; Stephen Finn; Johann Zimmermann; Phillip G Febbo; Massimo Loda
The isopeptidase USP2a protects human prostate cancer from apoptosis.
Cancer research 2006;66(17):8625-32.
2006: Shuji Ogino; Robert D Odze; Takako Kawasaki; Mohan Brahmandam; Gregory J Kirkner; Peter W Laird; Massimo Loda; Charlie S Fuchs
Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.
The American journal of surgical pathology 2006;30(9):1175-83.
2006: Farid Gizatullin; Yao Yao; Victor Kung; Matthew W Harding; Massimo Loda; Geoffrey I Shapiro
The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function.
Cancer research 2006;66(15):7668-77.
2006: Shuji Ogino; Mohan Brahmandam; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(8):1083-90.
2006: S Rossi; W Ou; D Tang; N Bhattacharya; Angelo P Dei Tos; Jonathan A Fletcher; Massimo Loda
Gastrointestinal stromal tumours overexpress fatty acid synthase.
The Journal of pathology 2006;209(3):369-75.
2006: Shuji Ogino; Mami Cantor; Takako Kawasaki; Mohan Brahmandam; Gregory J Kirkner; Daniel J Weisenberger; Mihaela Campan; Peter W Laird; Massimo Loda; Charlie S Fuchs
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
Gut 2006;55(7):1000-6.
2006: William K Oh; Julia Hayes; Carolyn Evan; Judith Manola; Daniel J George; Helen Waldron; Meaghan Donovan; John Varner; John Orechia; Beth Katcher; Diana Lu; Arthur Nevins; Renée L Wright; Lauren Tormey; James Talcott; Mark A Rubin; Massimo Loda; William R Sellers; Jerome P Richie; Philip W Kantoff; Jane C Weeks
Development of an integrated prostate cancer research information system.
Clinical genitourinary cancer 2006;5(1):61-6.
2006: Shuji Ogino; Mohan Brahmandam; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Neoplasia (New York, N.Y.) 2006;8(6):458-64.
2006: Raanan Berger; Douglas I Lin; Maria Nieto; Ewa Sicinska; Levi A Garraway; Heiner Adams; Sabina Signoretti; William C Hahn; Massimo Loda
Androgen-dependent regulation of Her-2/neu in prostate cancer cells.
Cancer research 2006;66(11):5723-8.
2006: Carmelo Nucera; Mario Vaccaro; Mariacarla Moleti; Carmen Priolo; Gaetano Tortorella; Adriano Angioni; Riccardo Ientile; Maria Antonia Violi; Massimo Loda; Francesco Trimarchi; Francesco Vermiglio
antiphospholipid antibodies syndrome associated with hyperhomocysteinemia related to MTHFR Gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome).
The Journal of clinical endocrinology and metabolism 2006;91(6):2021-6.
2006: Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Mami Cantor; Gregory J Kirkner; Donna Spiegelman; Michael G Makrigiorgos; Daniel J Weisenberger; Peter W Laird; Massimo Loda; Charlie S Fuchs
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.
The Journal of molecular diagnostics : JMD 2006;8(2):209-17.
2006: Barbara Benassi; Maurizio Fanciulli; Francesco Fiorentino; Alessandro Porrello; giovanna chiorino; Massimo Loda; Gabriella Zupi; Annamaria Biroccio
c-Myc phosphorylation is required for cellular response to oxidative stress.
Molecular cell 2006;21(4):509-19.
2006: Simona Nanni; Carmen Priolo; Annalisa Grasselli; Manuela D'Eletto; roberta merola; Fabiola Moretti; Michele Gallucci; Piero De Carli; Steno Sentinelli; Anna Maria Cianciulli; Marcella Mottolese; Paolo Carlini; Diego Arcelli; Mauro Helmer-Citterich; carlo gaetano; Massimo Loda; Alfredo Pontecorvi; Silvia Bacchetti; Ada Sacchi; Antonella Farsetti
Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
Molecular cancer research : MCR 2006;4(2):79-92.
2006: Laurie Feldman; Yuxun Wang; Johng S Rhim; Nandita Bhattacharya; Massimo Loda; Arthur Sytkowski
Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
The Prostate 2006;66(2):135-45.
2006: Phillip G Febbo; Aaron Thorner; Mark A Rubin; Massimo Loda; Philip W Kantoff; William K Oh; Todd R Golub; Daniel George
Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):152-8.
2006: Chiaki Takahashi; Bernardo Contreras; Tsuyoshi Iwanaga; Yujiro Takegami; Anke Bakker; Roderick T Bronson; Makoto Noda; Massimo Loda; Jennifer L Hunt; Mark E Ewen
Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor.
Nature genetics 2006;38(1):118-23.
2006: Sabina Signoretti; Massimo Loda
Defining cell lineages in the prostate epithelium.
Cell cycle (Georgetown, Tex.) 2006;5(2):138-41.
2006: Shuji Ogino; Mohan Brahmandam; Mami Cantor; Chungdak Namgyal; Takako Kawasaki; Gregory J Kirkner; Jeffrey A Meyerhardt; Massimo Loda; Charlie S Fuchs
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(1):59-68.
2005: Jean J Zhao; Zhenning Liu; Li Wang; Eyoung Shin; Massimo Loda; Thomas M Roberts
The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(51):18443-8.
2005: Shuji Ogino; Jeffrey A Meyerhardt; Mami Cantor; Mohan Brahmandam; jeffrey clark; Chungdak Namgyal; Takako Kawasaki; Kate Kinsella; Ann Michelini; Peter C Enzinger; Matthew H Kulke; David P Ryan; Massimo Loda; Charlie S Fuchs
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6650-6.
2005: Sabina Signoretti; Maira M Pires; Meghan Lindauer; James W Horner; Chiara Grisanzio; Sonya Dhar; Pradip Majumder; Frank D McKeon; Philip W Kantoff; William R Sellers; Massimo Loda
p63 regulates commitment to the prostate cell lineage.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(32):11355-60.
2005: Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Liying Yan; Mami Cantor; Chungdak Namgyal; Mari Mino-Kenudson; Gregory Y Lauwers; Massimo Loda; Charlie S Fuchs
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.
The Journal of molecular diagnostics : JMD 2005;7(3):413-21.
2005: Ji Luo; Cassandra L Sobkiw; Nicole M Logsdon; John M Watt; Sabina Signoretti; Fionnuala O'Connell; Eyoung Shin; Youngju Shim; Lily Pao; Benjamin G Neel; Ronald A DePinho; Massimo Loda; Lewis C Cantley
Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(29):10238-43.
2005: Phillip G Febbo; Jerome P Richie; Daniel J George; Massimo Loda; Judith Manola; Sridhar Shankar; Agnieszka Szot Barnes; Clare M C Tempany; William Catalona; Philip W Kantoff; William K Oh
Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5233-40.
2005: Terence M Williams; Ghada S Hassan; Jiangwei Li; Alex W Cohen; Freddy A Medina; Philippe G Frank; Richard G Pestell; Dolores Di Vizio; Massimo Loda; Michael P Lisanti
Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
The Journal of biological chemistry 2005;280(26):25134-45.
2005: James V Alvarez; Phillip G Febbo; Sridhar Ramaswamy; Massimo Loda; Andrea Richardson; David A Frank
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors.
Cancer research 2005;65(12):5054-62.
2005: Phillip G Febbo; Mark Lowenberg; Aaron R Thorner; Myles Brown; Massimo Loda; Todd R Golub
Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer.
The Journal of urology 2005;173(5):1772-7.
2005: Won K Han; Anwar Alinani; Chin-Lee Wu; Dror Michaelson; Massimo Loda; Francis J McGovern; Ravi Thadhani; Joseph V Bonventre
Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
Journal of the American Society of Nephrology : JASN 2005;16(4):1126-34.
2005: Zhennan Gu; Mark A Rubin; Yu Yang; Samuel E DePrimo; Hongjuan Zhao; Steven Horvath; James D Brooks; Massimo Loda; Robert E Reiter
Reg IV: a promising marker of hormone refractory metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2237-43.
2005: Mirna Lechpammer; Xiangjun Xu; F Henry Ellis; Nandita Bhattacharaya; Geoffrey I Shapiro; Massimo Loda
Flavopiridol reduces malignant transformation of the esophageal mucosa in p27 knockout mice.
Oncogene 2005;24(10):1683-8.
2004: Raanan Berger; Phillip G Febbo; Pradip K Majumder; Jean J Zhao; Shayan Mukherjee; Sabina Signoretti; K Thirza Campbell; William R Sellers; Thomas M Roberts; Massimo Loda; Todd R Golub; William C Hahn
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.
Cancer research 2004;64(24):8867-75.
2004: Tara-Jane Browne; Michelle S Hirsch; Gilbert Brodsky; William R Welch; Massimo Loda; Mark A Rubin
Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Human pathology 2004;35(12):1462-8.
2004: Chiaki Takahashi; Bernardo Contreras; Roderick T Bronson; Massimo Loda; Mark E Ewen
Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression.
Molecular and cellular biology 2004;24(23):10406-15.
2004: Vassil Kaimaktchiev; Luigi Terracciano; Luigi Tornillo; Hanspeter Spichtin; Dimitra Stoios; Marcel Bundi; Veselina Korcheva; Martina Mirlacher; Massimo Loda; Guido Sauter; Christopher L Corless
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(11):1392-9.
2004: Ian Krop; Audrey Player; Ana Tablante; Michele Taylor-Parker; Jaana Lahti-Domenici; Junya Fukuoka; Surinder Batra; Nickolas Papadopoulos; William G Richards; David J Sugarbaker; Renée L Wright; Judy Shim; Thomas A Stamey; William R Sellers; Massimo Loda; Matthew Meyerson; Ralph Hruban; Jin Jen; Kornelia Polyak
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.
Molecular cancer research : MCR 2004;2(9):489-94.
2004: Ceren G Korkmaz; Kemal Sami Korkmaz; Judith Manola; Zhijun Xi; Björn Risberg; Håvard E Danielsen; Janet Kung; William R Sellers; Massimo Loda; Fahri Saatcioglu
Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis.
The Journal of urology 2004;172(3):1134-9.
2004: Michael Murphy; John Carlson; Martin P Keough; Kevin P Claffey; Sabina Signoretti; Massimo Loda
Hypoxia regulation of the cell cycle in malignant melanoma: putative role for the cyclin-dependent kinase inhibitor p27.
Journal of cutaneous pathology 2004;31(7):477-82.
2004: Michelle Agostini; Sabrina D Silva; Karina G Zecchin; Ricardo D Coletta; Jacks Jorge; Massimo Loda; Edgard Graner
Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells.
Oral oncology 2004;40(7):728-35.
2004: Robert I Haddad; Lisa Weinstein; Tad J Wieczorek; Nandita Bhattacharya; Harry Raftopoulos; Martin W Oster; Xinxin Zhang; Vaughan M Latham; Rosemary Costello; Jarrod Faucher; Carolyn DeRosa; Murray Yule; Linda P Miller; Massimo Loda; Marshall R Posner; Geoffrey I Shapiro
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4680-7.
2004: Pradip K Majumder; Phillip G Febbo; Rachel Bikoff; Raanan Berger; Qi Xue; Louis M McMahon; Judith Manola; James Brugarolas; Timothy J McDonnell; Todd R Golub; Massimo Loda; Heidi A Lane; William R Sellers
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
Nature medicine 2004;10(6):594-601.
2004: Zhijun Xi; Tove Irene Klokk; Kemal Sami Korkmaz; Piotr Kurys; Cem Elbi; Björn Risberg; Håvard E Danielsen; Massimo Loda; Fahri Saatcioglu
Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer.
Cancer research 2004;64(7):2365-70.
2004: Edgard Graner; Dan Tang; Sabrina Rossi; Antonella Baron; Toshiro Migita; Lisa Weinstein; Mirna Lechpammer; Dieter Huesken; Johann Zimmermann; Sabina Signoretti; Massimo Loda
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.
Cancer cell 2004;5(3):253-61.
2004: Mirna Lechpammer; Josip Lukac; Stanislav Lechpammer; Dujo Kovacević; Massimo Loda; Zvonko Kusić
Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.
International journal of colorectal disease 2004;19(2):114-20.
2004: Robert H Vonderheide; Susan M Domchek; Joachim L Schultze; Daniel J George; Kara M Hoar; Dih-Yih Chen; Katherine Stephans; Kenkichi Masutomi; Massimo Loda; Zhinan Xia; Karen S Anderson; William C Hahn; Lee M Nadler
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):828-39.
2004: Alok S Pachori; Luis G Melo; Lunan Zhang; Massimo Loda; Richard E Pratt; Victor J Dzau
Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus.
Biochemical and biophysical research communications 2004;313(3):528-33.
2004: F H Ellis; Massimo Loda
p27 and Barrett's esophagus: a review*.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2004;17(2):113-7.
2004: Antonella Baron; Toshiro Migita; Dan Tang; Massimo Loda
Fatty acid synthase: a metabolic oncogene in prostate cancer?
Journal of cellular biochemistry 2004;91(1):47-53.
2003: Takao Hinoi; Massimo Loda; Eric R Fearon
Silencing of CDX2 expression in colon cancer via a dominant repression pathway.
The Journal of biological chemistry 2003;278(45):44608-16.
2003: Gilberto Moreira Júnior; Gisele W B Colleoni; Maria Giulia Cangi; Michael Murphy; Bradford Sherburne; José Orlando Bordin; Massimo Loda
Reciprocal Cdc25A and p27 expression in B-cell non-Hodgkin lymphomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2003;12(3):128-32.
2003: Marshall E Lieberfarb; Ming Lin; Mirna Lechpammer; Cheng Li; David M Tanenbaum; Phillip G Febbo; Renée L Wright; Judy Shim; Philip W Kantoff; Massimo Loda; Matthew Meyerson; William R Sellers
Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.
Cancer research 2003;63(16):4781-5.
2003: Yongqing Li; Wei-Hsuan Yu; Jian Ren; Wen Chen; Lei Huang; Surender Kharbanda; Massimo Loda; Donald Kufe
Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.
Molecular cancer research : MCR 2003;1(10):765-75.
2003: Sabrina Rossi; Edgard Graner; Phillip G Febbo; Lisa Weinstein; Nandita Bhattacharya; Tamas Onody; Glenn J Bubley; Steven P Balk; Massimo Loda
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
Molecular cancer research : MCR 2003;1(10):707-15.
2003: Pradip K Majumder; Jen Jen Yeh; Daniel J George; Phillip G Febbo; Jennifer Kum; Qi Xue; Rachel Bikoff; Hongfeng Ma; Philip W Kantoff; Todd R Golub; Massimo Loda; William R Sellers
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(13):7841-6.
2003: Robyn Kukoski; Brian Blonigen; Ettore Macri; Andrew A Renshaw; Michael Hoffman; Massimo Loda; Milton W Datta
p27 and cyclin E/D2 associations in testicular germ cell tumors: implications for tumorigenesis.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2003;11(2):138-43.
2003: Levi A Garraway; Douglas Lin; Sabina Signoretti; David Waltregny; James Dilks; Nandita Bhattacharya; Massimo Loda
Intermediate basal cells of the prostate: in vitro and in vivo characterization.
The Prostate 2003;55(3):206-18.
2003: Stacey B Leibowitz; Judy E Garber; Edward A Fox; Massimo Loda; Donald S Kaufman; Philip W Kantoff; William K Oh
Male patients with diagnoses of both breast cancer and prostate cancer.
The breast journal 2003;9(3):208-12.
2003: Mark D Fleming; Jack L Pinkus; Marcia V Fournier; Sarah W Alexander; Carmen Tam-Amersdorfer; Massimo Loda; Stephen E Sallan; Kim E Nichols; David F Carpentieri; Geraldine S Pinkus; Barrett J Rollins
Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis.
Blood 2003;101(7):2473-5.
2003: Hidefumi Sasaki; Chih-Yi Yu; Meiru Dai; Carmen Tam; Massimo Loda; Daniel Auclair; Lan Bo Chen; Anthony Elias
Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.
Breast cancer research and treatment 2003;77(3):245-52.
2003: Mattia Barbareschi; Bruno Murer; T V Colby; Marco Chilosi; E Macri; Massimo Loda; Claudio Doglioni
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
The American journal of surgical pathology 2003;27(2):141-9.
2003: Takashi Fujishita; Massimo Loda; Ross E Turner; Marinshine Gentler; Tatsuhiko Kashii; Oscar S Breathnach; Bruce E Johnson
Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.
Oncology 2003;64(4):399-406.
2003: Sabrina Rossi; Massimo Loda
The role of the ubiquitination-proteasome pathway in breast cancer: use of mouse models for analyzing ubiquitination processes.
Breast cancer research : BCR 2003;5(1):16-22.
2002: Vladimir Osipov; Jeffery T Keating; Peter N Faul; Massimo Loda; Milton W Datta
Expression of p27 and VHL in renal tumors.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2002;10(4):344-50.
2002: Michael H Weinstein; Sabina Signoretti; Massimo Loda
Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(12):1302-8.
2002: Neal Lindeman; David Waltregny; Sabina Signoretti; Massimo Loda
Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissection.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2002;11(4):187-92.
2002: David A Weinstein; CINDY ROY; Mark D Fleming; Massimo Loda; Joseph I Wolfsdorf; Nancy C Andrews
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.
Blood 2002;100(10):3776-81.
2002: William R Sellers; Massimo Loda
The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?
Cancer cell 2002;2(5):349-50.
2002: Kemal Sami Korkmaz; Cem Elbi; Ceren G Korkmaz; Massimo Loda; Gordon L Hager; Fahri Saatcioglu
Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer.
The Journal of biological chemistry 2002;277(39):36689-96.
2002: Nabeel Bardeesy; Manisha Sinha; Aram F Hezel; Sabina Signoretti; Nathaniel A Hathaway; Norman E Sharpless; Massimo Loda; Daniel R Carrasco; Ronald A DePinho
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.
Nature 2002;419(6903):162-7.
2002: Sabina Signoretti; Lucia Di Marcotullio; Andrea Richardson; Sridhar Ramaswamy; Beth Isaac; Montserrat Rue; Franco Monti; Massimo Loda; Michele Pagano
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
The Journal of clinical investigation 2002;110(5):633-41.
2002: Isabella Gazzoli; Massimo Loda; Judy E Garber; Sapna Syngal; Richard D Kolodner
A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor.
Cancer research 2002;62(14):3925-8.
2002: Siobhan S Wahlberg; James Schmeits; George Thomas; Massimo Loda; Judy E Garber; Sapna Syngal; Richard D Kolodner; Edward Fox
Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.
Cancer research 2002;62(12):3485-92.
2002: Dinesh Singh; Phillip G Febbo; Kenneth Ross; Donald G Jackson; Judith Manola; Christine Ladd; Pablo Tamayo; Andrew A Renshaw; Anthony V D'Amico; Jerome P Richie; Eric S Lander; Massimo Loda; Philip W Kantoff; Todd R Golub; William R Sellers
Gene expression correlates of clinical prostate cancer behavior.
Cancer cell 2002;1(2):203-9.
2002: William K Oh; Massimo Loda; Philip W Kantoff; Milos J Janicek
Progressive sclerosis of isolated foot metastasis of prostate cancer.
The Journal of urology 2002;167(3):1392.
2002: James DiRenzo; Sabina Signoretti; Noriaki Nakamura; Ramon Rivera-Gonzalez; William R Sellers; Massimo Loda; Myles Brown
Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.
Cancer research 2002;62(1):89-98.
2002: Nabeel Bardeesy; Jeffrey Morgan; Manisha Sinha; Sabina Signoretti; Shefali Srivastava; Massimo Loda; Glenn Merlino; Ronald A DePinho
Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.
Molecular and cellular biology 2002;22(2):635-43.
2001: Sridhar Ramaswamy; Pablo Tamayo; Ryan Rifkin; Sayan Mukherjee; Chen-Hsiang Yeang; Michael Angelo; Christine Ladd; Michael Reich; E Latulippe; Jill P Mesirov; Tomaso Poggio; W Gerald; Massimo Loda; Eric S Lander; Todd R Golub
Multiclass cancer diagnosis using tumor gene expression signatures.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(26):15149-54.
2001: Takao Hinoi; M Tani; Peter C Lucas; Karel Caca; Rodney L Dunn; E Macri; Massimo Loda; Henry D Appelman; Kathleen R Cho; Eric R Fearon
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon.
The American journal of pathology 2001;159(6):2239-48.
2001: Arindam Bhattacharjee; W G Richards; J Staunton; Cheng Li; S Monti; P Vasa; C Ladd; Javad Beheshti; R Bueno; M Gillette; Massimo Loda; Griffin Weber; E J Mark; Eric S Lander; W Wong; Bruce E Johnson; Todd R Golub; David J Sugarbaker; Matthew Meyerson
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(24):13790-5.
2001: FH Ellis; X Xu; Matthew H Kulke; J LoCicero; Massimo Loda
Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice.
The Journal of thoracic and cardiovascular surgery 2001;122(4):809-14.
2001: L M DeSalle; Esther Latres; D Lin; E Graner; A Montagnoli; R T Baker; Michele Pagano; Massimo Loda
The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein.
Oncogene 2001;20(39):5538-42.
2001: Hidefumi Sasaki; K M Lo; LB Chen; Daniel Auclair; Yoshiaki Nakashima; Satoru Moriyama; Ichiro Fukai; C Tam; Massimo Loda; Yoshitaka Fujii
Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.
Japanese journal of cancer research : Gann 2001;92(8):869-73.
2001: Sabina Signoretti; Massimo Loda
Estrogen receptor beta in prostate cancer: brake pedal or accelerator?
The American journal of pathology 2001;159(1):13-6.
2001: Milton W Datta; E Macri; Sabina Signoretti; Andrew A Renshaw; Massimo Loda
Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(5):437-42.
2001: David Waltregny; Irwin Leav; Sabina Signoretti; P Soung; D Lin; FB Merk; Jason Y Adams; N Bhattacharya; N Cirenei; Massimo Loda
Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
Molecular endocrinology (Baltimore, Md.) 2001;15(5):765-82.
2001: Matthew H Kulke; K S Thakore; G Thomas; H Wang; Massimo Loda; Charis Eng; Robert D Odze
Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma.
Cancer 2001;91(8):1451-7.
2001: Matthew H Kulke; Robert D Odze; K S Thakore; G Thomas; H Wang; Massimo Loda; Charis Eng
Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.
British journal of cancer 2001;84(6):748-53.
2000: F Gesbert; William R Sellers; Sabina Signoretti; Massimo Loda; James D Griffin
BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
The Journal of biological chemistry 2000;275(50):39223-30.
2000: Sabina Signoretti; R Montironi; J Manola; A Altimari; Carmen Tam-Amersdorfer; Glenn J Bubley; S Balk; G Thomas; I Kaplan; Lynn Hlatky; Philip Hahnfeldt; Philip W Kantoff; Massimo Loda
Her-2-neu expression and progression toward androgen independence in human prostate cancer.
Journal of the National Cancer Institute 2000;92(23):1918-25.
2000: Sabina Signoretti; David Waltregny; J Dilks; B Isaac; D Lin; Levi A Garraway; A Yang; R Montironi; F McKeon; Massimo Loda
p63 is a prostate basal cell marker and is required for prostate development.
The American journal of pathology 2000;157(6):1769-75.
2000: N Nakamura; S Ramaswamy; Francisca Vazquez; Sabina Signoretti; Massimo Loda; William R Sellers
Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.
Molecular and cellular biology 2000;20(23):8969-82.
2000: Massimo Loda
p27KIP1: androgen regulation and prognostic significance in prostate cancer.
Advances in clinical pathology : the official journal of Adriatic Society of Pathology 2000;4(4):226-32.
2000: Michelangelo Fiorentino; Annalisa Altimari; Antonia D'Errico; B Cukor; Chiara Barozzi; Massimo Loda; Walter Franco Grigioni
Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):3966-72.
2000: MG Cangi; B Cukor; P Soung; Sabina Signoretti; G Moreira; M Ranashinge; B Cady; M Pagano; Massimo Loda
Role of the Cdc25A phosphatase in human breast cancer.
The Journal of clinical investigation 2000;106(6):753-61.
2000: M Murphy; Sabina Signoretti; M E Kadin; Massimo Loda
Detection of TCR-gamma gene rearrangements in early mycosis fungoides by non-radioactive PCR-SSCP.
Journal of cutaneous pathology 2000;27(5):228-34.
2000: L Gu; S Tseng; R M Horner; Carmen Tam-Amersdorfer; Massimo Loda; Barrett J Rollins
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1.
Nature 2000;404(6776):407-11.
2000: Z Gu; G Thomas; Joyce Yamashiro; I Peter Shintaku; Frederick Dorey; Arthur B Raitano; Owen N Witte; Jonathan W Said; Massimo Loda; Robert E Reiter
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
Oncogene 2000;19(10):1288-96.
2000: Massimo Loda; X Xu; A Pession; A Vortmeyer; F Giangaspero
Membranous expression of glucose transporter-1 protein (GLUT-1) in embryonal neoplasms of the central nervous system.
Neuropathology and applied neurobiology 2000;26(1):91-7.
2000: X Xu; J LoCicero; E Macri; Massimo Loda; FH Ellis
Barrett's esophagus and associated adenocarcinoma in a mouse surgical model.
The Journal of surgical research 2000;88(2):120-4.
2000: DS Chiaur; S Murthy; Carlo Cenciarelli; W Parks; Massimo Loda; Giorgio Inghirami; D Demetrick; Michele Pagano
Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors.
Cytogenetics and cell genetics 2000;88(3-4):255-8.
2000: Urmila Khettry; N Anand; Fredric D Gordon; Roger L Jenkins; Steven R Tahan; Massimo Loda; W David Lewis
Recurrent hepatitis B, hepatitis C, and combined hepatitis B and C in liver allografts: a comparative pathological study.
Human pathology 2000;31(1):101-8.
2000: Robert E Reiter; I Sato; G Thomas; J Qian; Z Gu; Tetsuro Watabe; Massimo Loda; R B Jenkins
Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
Genes, chromosomes & cancer 2000;27(1):95-103.
1999: Sabina Signoretti; M Murphy; P Puddu; John F DeCoteau; Tullio Faraggiana; Marshall E Kadin; Massimo Loda
Clonality of cutaneous B-cell infiltrates determined by microdissection and immunoglobulin gene rearrangement.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1999;8(4):176-82.
1999: M Murphy; Sabina Signoretti; Imad Nasser; B Sherburne; Massimo Loda
Detection of concurrent/recurrent non-Hodgkin's lymphoma in effusions by PCR.
Human pathology 1999;30(11):1361-6.
1999: S Walsh; M Murphy; M Silverman; Robert D Odze; Donald A Antonioli; Harvey Goldman; Massimo Loda
p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.
The American journal of pathology 1999;155(5):1511-8.
1999: M E McMenamin; P Soung; S Perera; I Kaplan; Massimo Loda; William R Sellers
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
Cancer research 1999;59(17):4291-6.
1999: S V Walsh; Massimo Loda; CM Torres; Donald A Antonioli; Robert D Odze
P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study.
The American journal of surgical pathology 1999;23(8):963-9.
1999: S Bao; M S Chang; Daniel Auclair; Y Sun; Yihan Wang; W K Wong; J Zhang; Y Liu; X Qian; R Sutherland; C Magi-Galluzi; Ellen Weisberg; E Y Cheng; L Hao; H Sasaki; M S Campbell; Stine-Kathrein Kraeft; Massimo Loda; K M Lo; Lan Bo Chen
HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint gene rad17, is overexpressed in colon carcinoma.
Cancer research 1999;59(9):2023-8.
1999: Irwin Leav; FB Merk; K F Lee; Massimo Loda; M Mandoki; John E McNeal; Shuk-Mei Ho
Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions.
The American journal of pathology 1999;154(3):863-70.
1999: S Sharifi; M Murphy; Massimo Loda; Geraldine S Pinkus; Urmila Khettry
Nodular lymphoid lesion of the liver: an immune-mediated disorder mimicking low-grade malignant lymphoma.
The American journal of surgical pathology 1999;23(3):302-8.
1999: Sabina Signoretti; M Murphy; MG Cangi; P Puddu; Marshall E Kadin; Massimo Loda
Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis.
The American journal of pathology 1999;154(1):67-75.
1998: C Magi-Galluzzi; M Murphy; M G Cangi; Massimo Loda
Proliferation, apoptosis and cell cycle regulation in prostatic carcinogenesis.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1998;20(5):343-50.
1998: G V Thomas; K Szigeti; M Murphy; GF Draetta; M Pagano; Massimo Loda
Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.
The American journal of pathology 1998;153(3):681-7.
1998: J M Jessup; Massimo Loda
Prognostic markers in rectal carcinoma.
Seminars in surgical oncology 1998;15(2):131-40.
1998: M Yang; Massimo Loda; A J Sytkowski
Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines.
Cancer research 1998;58(16):3732-5.
1998: C Magi-Galluzzi; R Montironi; M G Cangi; KI Wishnow; Massimo Loda
Mitogen-activated protein kinases and apoptosis in PIN.
Virchows Archiv : an international journal of pathology 1998;432(5):407-13.
1998: S P Singh; J Lipman; Harvey Goldman; FH Ellis; L Aizenman; MG Cangi; Sabina Signoretti; D S Chiaur; M Pagano; Massimo Loda
Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Cancer research 1998;58(8):1730-5.
1998: P Capodieci; C Magi-Galluzzi; G Moreira; R Zeheb; Massimo Loda
Automated in situ hybridization: diagnostic and research applications.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(2):69-75.
1998: L Bao; Massimo Loda; B R Zetter
Thymosin beta15 expression in tumor cell lines with varying metastatic potential.
Clinical & experimental metastasis 1998;16(3):227-33.
1998: R M Yang; J Naitoh; M Murphy; H J Wang; J Phillipson; Jean B deKernion; Massimo Loda; Robert E Reiter
Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
The Journal of urology 1998;159(3):941-5.
1998: Robert E Reiter; Z Gu; Tetsuro Watabe; G Thomas; K Szigeti; E Davis; M Wahl; Sazuku Nisitani; Joyce Yamashiro; M M Le Beau; Massimo Loda; Owen N Witte
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1735-40.
1998: E Macri; Massimo Loda
Role of p27 in prostate carcinogenesis.
Cancer metastasis reviews 1998;17(4):337-44.
1998: J Milburn Jessup; Massimo Loda; Ronald Bleday
Clinical and molecular prognostic factors in sphincter-preserving surgery for rectal cancer.
Seminars in radiation oncology 1998;8(1):54-69.
1997: Vincenzo Esposito; A Baldi; Antonio De Luca; AM Groger; Massimo Loda; GG Giordano; Mario Caputi; F Baldi; M Pagano; Antonio Giordano
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.
Cancer research 1997;57(16):3381-5.
1997: C Magi-Galluzzi; X Xu; Lynn Hlatky; Philip Hahnfeldt; I Kaplan; P Hsiao; C Chang; Massimo Loda
Heterogeneity of androgen receptor content in advanced prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(8):839-45.
1997: FH Ellis; Massimo Loda
Role of surveillance endoscopy, biopsy and biomarkers in early detection of Barrett's adenocarcinoma.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 1997;10(3):165-71.
1997: P Tan; B Cady; M Wanner; P Worland; B Cukor; C Magi-Galluzzi; Philip T Lavin; GF Draetta; M Pagano; Massimo Loda
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
Cancer research 1997;57(7):1259-63.
1997: Mario Lise; Massimo Loda; Michelangelo Fiorentino; A M Mercurio; I C Summerhayes; Philip T Lavin; J Milburn Jessup
Association between sucrase-isomaltase and p53 expression in colorectal cancer.
Annals of surgical oncology 1997;4(2):176-83.
1997: Michael F Kane; Massimo Loda; GM Gaida; J Lipman; R Mishra; H Goldman; J M Jessup; Richard D Kolodner
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.
Cancer research 1997;57(5):808-11.
1997: A K Lee; Massimo Loda; G Mackarem; Silvano Bosari; R A DeLellis; G J Heatley; K Hughes
Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bNOMO): clinicopathologic features and outcome.
Cancer 1997;79(4):761-71.
1997: Massimo Loda; B Cukor; S W Tam; Philip T Lavin; Michelangelo Fiorentino; GF Draetta; J Milburn Jessup; M Pagano
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
Nature medicine 1997;3(2):231-4.
1997: C Magi-Galluzzi; R Mishra; M Fiorentino; R Montironi; H Yao; P Capodieci; KI Wishnow; I Kaplan; Philip J S Stork; Massimo Loda
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Laboratory investigation; a journal of technical methods and pathology 1997;76(1):37-51.
1996: D Shibata; Michael A Reale; Philip T Lavin; M Silverman; Eric R Fearon; Glenn Steele; J M Jessup; Massimo Loda; I C Summerhayes
The DCC protein and prognosis in colorectal cancer.
The New England journal of medicine 1996;335(23):1727-32.
1996: L Bao; Massimo Loda; P A Janmey; R Stewart; Bela Anand-Apte; Bruce R Zetter
Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer.
Nature medicine 1996;2(12):1322-8.
1996: Massimo Loda; P Capodieci; R Mishra; H Yao; Christopher L Corless; W Grigioni; Y Wang; C Magi-Galluzzi; Philip J S Stork
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.
The American journal of pathology 1996;149(5):1553-64.
1996: Irwin Leav; C M Galluzzi; J Ziar; Philip J S Stork; Shuk-Mei Ho; Massimo Loda
Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
Laboratory investigation; a journal of technical methods and pathology 1996;75(3):361-70.
1996: Massimo Loda; M Fiorentino; J Meckler; Urmila Khettry; D Lewis; K Washburn; R Jenkins; A E Mendoza; John Samuelson
Hepatitis C virus reinfection in orthotopic liver transplant patients with or without concomitant hepatitis B infection.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1996;5(2):81-7.
1996: M G Joshi; A K Lee; Massimo Loda; M G Camus; C Pedersen; G J Heatley; K S Hughes
Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
Cancer 1996;77(3):490-8.
1996: C Magi-Galluzzi; Massimo Loda
Molecular events in the early phases of prostate carcinogenesis.
European urology 1996;30(2):167-76.
1995: Silvano Bosari; A Marchetti; F Buttitta; Daniela Graziani; Giuseppe Borsani; Massimo Loda; G Bevilacqua; Guido Coggi
Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1995;4(4):249-55.
1995: J Milburn Jessup; P T Lavin; C W Andrews; Massimo Loda; A Mercurio; B D Minsky; C Mies; B Cukor; Ronald Bleday; Glenn Steele
Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma.
Diseases of the colon and rectum 1995;38(12):1257-64.
1995: K Galaktionov; A K Lee; J Eckstein; G Draetta; J Meckler; Massimo Loda; D Beach
CDC25 phosphatases as potential human oncogenes.
Science (New York, N.Y.) 1995;269(5230):1575-7.
1995: W V Kastrinakis; N Ramchurren; K M Rieger; D T Hess; Massimo Loda; Glenn Steele; I C Summerhayes
Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.
Oncogene 1995;11(4):647-52.
1995: L Columbyova; Massimo Loda; D T Scadden
Thrombopoietin receptor expression in human cancer cell lines and primary tissues.
Cancer research 1995;55(16):3509-12.
1995: Fredric D Gordon; H Anastopoulos; Urmila Khettry; Massimo Loda; Roger L Jenkins; W David Lewis; C Trey
Hepatitis C infection: a rare cause of fulminant hepatic failure.
The American journal of gastroenterology 1995;90(1):117-20.
1994: Massimo Loda; J Lipman; B Cukor; M Bur; P Kwan; R A DeLellis
Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Human pathology 1994;25(10):1050-6.
1994: Massimo Loda
Polymerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes.
Human pathology 1994;25(6):564-71.
1994: Franz Fogt; Alexander O Vortmeyer; G Ahn; U De Girolami; R B Hunt; T Daly; Massimo Loda
Neural cyst of the ovary with central nervous system microvasculature.
Histopathology 1994;24(5):477-80.
1994: Massimo Loda; Franz Fogt; Frank S French; M Posner; B Cukor; H T Aretz; Nada Alsaigh
Androgen receptor immunohistochemistry on paraffin-embedded tissue.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(3):388-91.
1993: G Fabbretti; C Valenti; Massimo Loda; M Brisigotti; C Cozzutto; Gian Paolo Tonini; F Callea
N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma).
Human pathology 1993;24(3):294-7.
1993: M Badiali; Achille Iolascon; Massimo Loda; B W Scheithauer; Giuseppe Basso; G P Trentini; Felice Giangaspero
p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1993;2(1):23-8.
1992: Felice Giangaspero; L Rigobello; M Badiali; Massimo Loda; L Andreini; Giuseppe Basso; F Zorzi; Anna Montaldi
Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.
The American journal of surgical pathology 1992;16(7):687-93.
1992: A K Lee; B Wiley; J M Dugan; W H Hamilton; Massimo Loda; G J Heatley; L Cook; M L Silverman
Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
Pathology, research and practice 1992;188(4-5):428-32.
1992: Massimo Loda; Felice Giangaspero; M Badiali; P Capodieci; Andrea Pession
p53 gene expression in medulloblastoma by quantitative polymerase chain reaction.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1992;1(1):36-44.
1992: A K Lee; B Wiley; Massimo Loda; Silvano Bosari; J M Dugan; W Hamilton; G J Heatley; L Cook; M L Silverman
DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(1):61-7.
1991: Philip J S Stork; Massimo Loda; Silvano Bosari; B Wiley; K Poppenhusen; H Wolfe
Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Oncogene 1991;6(5):857-62.
1991: Massimo Loda; A E Mendoza; C O'Hara; J M Crawford; M Federman; H Goodman
Well-differentiated hepatocellular carcinoma associated with long-term survival. Report of two cases.
Virchows Archiv. A, Pathological anatomy and histopathology 1991;418(6):551-6.
1985: D F Devereux; Trevor Redgrave; Massimo Loda; G H Clowes; P J Deckers
Tumor-associated metabolism in the rat is a unique physiologic entity.
The Journal of surgical research 1985;38(2):149-53.